Canadian life sciences and technology company Botaneco has announced the compliance of its oleosome-based sunscreen formulation with the FDA sunscreen monograph, which can now be marketed in the US with an SPF 30 claim.
The American Academy of Dermatology (AAD) has announced its intention to phase out its Seal of Recognition program for sunscreen products with the expectation that the Food and Drug Administration (FDA) will soon issue a sunscreen monograph.
